Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 15,884 | 19,344 | 11,945 | 8,857 | 9,978 |
| Gross Profit | 15,884 | 19,344 | 11,945 | 8,857 | 9,978 |
| Operating Expenses | 13,017 | 15,001 | 10,053 | 14,614 | 16,611 |
| Operating Income | 2,867 | 4,343 | 1,892 | -5,757 | -6,633 |
| Interest Expense | 12 | 15 | 16 | 6,457 | 1,340 |
| Other Income | 272 | -236 | 284 | 5,081 | 405 |
| Pre-tax Income | 3,127 | 4,092 | 2,160 | -7,133 | -7,568 |
| Net Income Continuous | 3,127 | 4,092 | 2,160 | -7,133 | -7,568 |
| Minority Interests | -983 | -1,009 | -939 | -1,713 | -1,489 |
| Net Income | $4,110 | $5,101 | $3,099 | $-5,420 | $-6,079 |
| EPS Basic Total Ops | 1.00 | 1.30 | 0.80 | -1.40 | -1.50 |
| EPS Basic Continuous Ops | 0.78 | 1.03 | 0.55 | -1.79 | -1.90 |
| EPS Diluted Total Ops | 1.00 | 1.30 | 0.80 | -1.40 | -1.50 |
| EPS Diluted Continuous Ops | 0.78 | 1.03 | 0.55 | -1.79 | -1.90 |
| EBITDA(a) | $3,626 | $5,028 | $2,526 | $-5,147 | $-6,120 |